Danaher Corp (DHR) concluded trading on Wednesday at a closing price of $223.73, with 11.4 million shares of worth about $2.55 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -17.64% during that period and on January 29, 2025 the price saw a loss of about -9.73%. Currently the company’s common shares owned by public are about 719.10M shares, out of which, 692.95M shares are available for trading.
Stock saw a price change of -8.37% in past 5 days and over the past one month there was a price change of -3.26%. Year-to-date (YTD), DHR shares are showing a performance of -2.54% which decreased to -3.98% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $225.42 but also hit the highest price of $281.70 during that period. The average intraday trading volume for Danaher Corp shares is 3.09 million. The stock is currently trading -6.23% below its 20-day simple moving average (SMA20), while that difference is down -5.07% for SMA50 and it goes to -11.72% lower than SMA200.
Danaher Corp (NYSE: DHR) currently have 719.10M outstanding shares and institutions hold larger chunk of about 80.64% of that.
The stock has a current market capitalization of $161.59B and its 3Y-monthly beta is at 0.85. PE ratio of stock for trailing 12 months is 42.32, while it has posted earnings per share of $5.29 in the same period. Its PEG reads 4.37 and has Quick Ratio of 1.05 while making debt-to-equity ratio of 0.32. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DHR, volatility over the week remained 2.92% while standing at 2.45% over the month.
Stock’s fiscal year EPS is expected to rise by 6.30% while it is estimated to increase by 12.14% in next year. EPS is likely to grow at an annualized rate of 9.68% for next 5-years, compared to annual growth of 9.03% made by the stock over the past 5-years.
Coverage by Guggenheim stated Danaher Corp (DHR) stock as a Buy in their note to investors on December 19, 2024, suggesting a price target of $275 for the stock. On December 13, 2024, BofA Securities Upgrade their recommendations, while on October 31, 2024, Wolfe Research Upgrade their ratings for the stock with a price target of $285. Stock get an Overweight rating from Stephens on October 01, 2024.
